ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 2604

$654K Total Retail Price of All Prescriptions

Rank: 97 out of 2604

498 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,880 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 415 230 1 2
OMEPRAZOLE 371 230 2 5
LISINOPRIL 364 270 3 3
HYDROCODONE-ACETAMINOPHEN 346 228 S3 4 1
LEVOTHYROXINE SODIUM 299 161 5 4
AMLODIPINE BESYLATE 263 214 6 6
METFORMIN HCL 158 123 7 7
ATENOLOL 144 96 8 11
FUROSEMIDE 142 92 9 8
LOSARTAN POTASSIUM 139 107 10 20
METOPROLOL TARTRATE 134 87 11 9
PRAVASTATIN SODIUM 132 109 12 14
ATORVASTATIN CALCIUM 128 110 13 19
HYDROCHLOROTHIAZIDE 126 107 14 10
CITALOPRAM HBR 112 62 15 18
WARFARIN SODIUM 112 93 15 13
SERTRALINE HCL 110 56 17 23
ADVAIR DISKUS 105 90 18 41
PROAIR HFA 101 75 19 27
LOVASTATIN 95 58 20 24
OXYCODONE HCL-ACETAMINOPHEN 95 17 S2 20 106
GABAPENTIN 94 42 22 12
METOPROLOL SUCCINATE 91 67 23 17
POTASSIUM CHLORIDE 91 51 23 16
BENAZEPRIL HCL 88 53 25 139
CYMBALTA 84 43 26 44
SPIRIVA 83 53 27 45
BUMETANIDE 82 58 28 70
GLYBURIDE 77 77 R 29 83
PAROXETINE HCL 76 26 30 62
PREDNISONE 71 51 31 34
TRAMADOL HCL 71 47 31 15
FLUTICASONE PROPIONATE 71 56 31 31
CRESTOR 70 54 34 47
PANTOPRAZOLE SODIUM 68 19 35 64
ALLOPURINOL 67 51 36 35
SINGULAIR 66 51 37 120
PEN NEEDLE 66 47 37 145
ROPINIROLE HCL 63 49 39 102
CYCLOBENZAPRINE HCL 62 11 R 40 43
LANTUS SOLOSTAR 61 52 41 84
IBUPROFEN 60 14 42 32
CARVEDILOL 60 47 42 26
RANITIDINE HCL 58 24 44 25
TAMSULOSIN HCL 57 34 45 30
ZOLPIDEM TARTRATE 56 41 46 21
KLOR-CON M20 55 52 47 86
LYRICA 53 23 48 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.